These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25031885)

  • 1. Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia.
    Fukumoto S
    Endocrinol Metab (Seoul); 2014 Jun; 29(2):136-43. PubMed ID: 25031885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO).
    Kinoshita Y; Takashi Y; Ito N; Ikegawa S; Mano H; Ushiku T; Fukayama M; Nangaku M; Fukumoto S
    Bone Rep; 2019 Jun; 10():100192. PubMed ID: 30627598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment.
    Fukumoto S
    J Mol Endocrinol; 2021 Feb; 66(2):R57-R65. PubMed ID: 33295878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced osteomalacia.
    Florenzano P; Gafni RI; Collins MT
    Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption.
    Hidaka N; Kato H; Koga M; Katsura M; Oyama Y; Kinoshita Y; Fukumoto S; Makita N; Nangaku M; Ito N
    Bone Rep; 2021 Dec; 15():101144. PubMed ID: 34901334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
    Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Superficial Blood Sampling to Localize a Fibroblast Growth Factor-23-Producing Tumor.
    Rikitake J; Ashida K; Nagayama A; Inoguchi Y; Hasuzawa N; Koganemaru M; Hamada T; Moritaka K; Demiya M; Sako T; Akiba J; Hiraoka K; Nomura M
    Am J Case Rep; 2024 Apr; 25():e943152. PubMed ID: 38613142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y; Fukumoto S
    Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
    Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reports of 17 Chinese patients with tumor-induced osteomalacia.
    Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
    J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor-induced Hypophosphatemic Osteomalacia Caused by a Chest Wall Tumor].
    Kin Y; Ogawa H; Matsumoto G; Mitsui S; Matsumoto T; Nishioka Y; Sakai S; Kimura K; Shimizu N; Hokka D; Tanaka Y; Maniwa Y
    Kyobu Geka; 2019 Aug; 72(8):570-573. PubMed ID: 31353346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia.
    Ito N; Hidaka N; Kato H
    Endocrinol Metab (Seoul); 2024 Apr; 39(2):255-261. PubMed ID: 38467164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF23 and Hypophosphatemic Rickets/Osteomalacia.
    Takashi Y; Kawanami D; Fukumoto S
    Curr Osteoporos Rep; 2021 Dec; 19(6):669-675. PubMed ID: 34755323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases].
    Fukumoto S
    Clin Calcium; 2015 Jan; 25(1):37-44. PubMed ID: 25530521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
    Imel EA; Peacock M; Pitukcheewanont P; Heller HJ; Ward LM; Shulman D; Kassem M; Rackoff P; Zimering M; Dalkin A; Drobny E; Colussi G; Shaker JL; Hoogendoorn EH; Hui SL; Econs MJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2055-61. PubMed ID: 16551733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.].
    Kinoshita Y
    Clin Calcium; 2018; 28(10):1373-1379. PubMed ID: 30269120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.